Outlook Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Outlook Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $4.0M | 548k | 7.38 |
2024-03-31 | $4.1M | 341k | 11.94 |